The Remdesivir is a broad-spectrum antiviral medication. It’s an antiviral drug that targeted and inhabits the replication and development of viral pathogens. The Remdesivir Drugs use for emergency treatment to the Covid-19 patients. In Nov 2020 updated guideline from WHO (World Health Organisation) to about the Remdesivir conditional recommendations against the Covid-19. Now, it is used in around 50 plus countries as per the WHO guidelines.
Remdesivir Manufacturers In India
On 23 June 2020, India has granted emergency used of Remdesivir Drung and its marketing approval of generic Remdesivir manufactured by Two Gilead Sciences licensees to the Cipla and Hetero Drugs Limited.
In April 2021, The production capacity of Remdesivir used for Covid-19 treatment has increased from 38 lakh to 1.19 crore dose per month due to a sudden spike in Covid-19 patients. The Remdesivir is manufactured in India under the Gilead Life Sciences license to the Seven pharmaceutical industries such as Cipla, Hetero, Dr. Reddy, Zydus Cadila, Syngene Mulan, and Jubilant Pharma.
SeeThe Cipla Company is an Indian multinational pharmaceutical industry and it’s primarily developed medicine to treat Arthritis, Diabetes, Covid-19, Respiratory, Depression, and many more. The Cipla Headquartered placed at Mumbai, Maharashtra.
As per the Gilead Sciences licensees approved for Remdesivir manufactured by Cipla in India. In July 2020, The Cipla officially announced the introduction of Remdesivir under the brand name CIPREMI in India. The DCGI ( Drugs Controller General of India ) approved for restricted emergency used in Covid-19 treatment of critical patients. The Cipla is the World’s Largest manufacturers of antiretroviral drugs.
Hetero Drugs Limited –
Hetero Drugs Limited is India’s reputed pharmaceutical company and the world’s large producer of anti-retroviral drugs. Its headquarters situated in Hyderabad, India. It’s also got an approval license from Gilead Sciences of Covid-19 Drug Remdesivir. It’s launched under the brand name Covifor and obtaining approval from DCGI and CDSCO ( Central Drugs Standard Control Organisation ).
On 29 July 2020, The Hetero also launched the Covifor version of the Antiviral drug Favipiravir under the brand name Favivir. It was approved by the DGCI and used in the treatment of mild and moderate Covid-19 patients.
Remdesivir Price In India –
The Remdesivir drug prices varied from Rs 899 to 5000 as per the pharma firms. In April 2021 Indian Government reduced the Remdesivir price by nearly Rs 2000 per injection. The Remdesivir prices go high in the unofficial market in the current scenario due to a sudden spike in Covid-19 cases. The e-commerce platform OLx runs the advertisement of Remdesivir drug at the cost of Rs 6000 per injection.
Remdesivir Side Effects –
- The infusion-related reaction has been seen around the time remdesivir was given. Sign & Symptoms- Low blood pressure, Nausea, Vomiting, Sweating, and Shivering.
- Increase in the level of liver enzymes.
- Show some allergic reactions such as Rashes, Itching, Swelling, ( face, tongue, and throat area ) trouble in breathing, etc.
Zydus Cadila limited-
Cadila healthcare limited is an Indian multinational pharma company headquartered in Ahmedabad, Gujrat. It primarily engaged with the manufacturing of generic drugs or medicine. Cadila has three activity ingredients sites in India, the Vadodara unit, Ankleshwar, and Patalganga unit. Zydus Cadila, also among the several manufacturing companies of Remdesivir viral drug in India, received the licensing agreement from Gilead Sciences.
Dr. Reddy Laboratories-
Dr. Reddy Laboratories is an Indian leading multinational pharma industry, headquarters in Telangana, India. The company was founded in 1984 by Anji Reddy. Dr. Reddy manufacturers over 190 medications, 60 active pharmaceutical ingredients for critical care, drugs manufactured, biotechnology products, and diagnostic kits. In 2021, the second wave of Covid-19 and the shortage of Remdesivir viral drugs got a licensing agreement from Gilead Sciences. Dr. Reddy manufactures the Remdesivir under the brand name Redux for the Indian market.
Syngene International limited-
Syngene international limited is an integrated contract-based research, development, and manufacturing pharma industry. It was founded in 1994, headquartered in Bengaluru, Karnataka. Syngene caters to a wide range of sectors such as biotechnology, pharmaceutical, animal health, nutrition specialty chemicals, and consumer products. In 2021, Syngene was also approved by the Gilead sciences for manufacturers of Remdesivir viral drugs, considering the current demands of Remdesivir.